Pharmacokinetic and Pharmacodynamic Profile of Rosuvastatin in Patients with End-Stage Renal Disease on Chronic Haemodialysis

被引：0
|
作者：
Bruce K. Birmingham
Suzanne K. Swan
Tom Puchalski
Pat Mitchell
Connie Azumaya
Julie Zalikowski
Yi Wang
机构：
[1] AstraZeneca,
[2] DaVita Clinical Research & Hennepin County Medical Center,undefined
[3] Purdue Pharma,undefined
[4] One Stamford Forum,undefined
来源：
Clinical Drug Investigation | 2013年 / 33卷
关键词：
Rosuvastatin; ESRD Patient; Severe Renal Impairment; Chronic Haemodialysis; ISTD;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：233 / 241
页数：8
相关论文
共 50 条
  • [31] A pharmacokinetic and pharmacodynamic simulation analysis of rapacuronium administration in end stage renal disease patients
    Schow, AJ
    Cortinez, LI
    Hsu, YW
    Somma, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1067 - 1067
  • [32] Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease
    Joki, N
    Hase, H
    Nakamura, R
    Yamaguchi, T
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (04) : 718 - 723
  • [33] Prevalence of risk factors for foot ulceration in patients with end-stage renal disease on haemodialysis
    Kaminski, M.
    Frescos, N.
    Tucker, S.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (06) : E120 - E128
  • [34] Do Transferrin Levels Predict Haemodialysis Adequacy in Patients with End-Stage Renal Disease?
    Tarantino, Giovanni
    Vinciguerra, Mauro
    Ragosta, Annalisa
    Citro, Vincenzo
    Conforti, Paolo
    Salvati, Giovanni
    Sorrentino, Aniello
    Barretta, Luca
    Balsano, Clara
    Capone, Domenico
    NUTRIENTS, 2019, 11 (05)
  • [35] Chronic pain in end-stage renal disease
    Davison, SN
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2005, 12 (03) : 326 - 334
  • [36] The Effect Of Haemodialysis On Visual Acuity And Retinal Structure In Patients With End-Stage Renal Disease
    Liew, S.
    James, M.
    Curtin, K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (SUPPL 2) : 8 - 8
  • [37] Pharmacokinetics of a parenteral carbapenem, biapenem, in patients with end-stage renal disease and influence of haemodialysis
    Nagashima, S
    Kozawa, O
    Otsuka, T
    Kohno, K
    Minamoto, M
    Yokokawa, M
    Kanamaru, M
    Uematsu, T
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (05) : 839 - 842
  • [38] LIPOPROTEIN PROFILE, HSCRP AND SERUM PARAOXONASE ACTIVITY IN END-STAGE RENAL DISEASE PATIENTS ON LONG-TERM HAEMODIALYSIS
    Lahrach, H.
    Taki, H.
    Kettani, A.
    Ghalim, N.
    Ramdani, B.
    Saile, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 36 - 36
  • [39] Toward a trajectory of adjustment in women with end-stage renal disease on haemodialysis
    Tanyi, Ruth A.
    Werner, Joan Stehle
    JOURNAL OF CLINICAL NURSING, 2008, 17 (5A) : 43 - 50
  • [40] Safety and pharmacokinetic profile of apixaban in end-stage renal disease: A real-world analysis
    Tseng, Chen I.
    Roddick, Alistair J.
    Bottomley, Matthew J.
    Shapiro, Susan
    Udayaraj, Udaya
    EJHAEM, 2023, 4 (01): : 291 - 293
12345